<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220528055007N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-08-31</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>Effect of education and virtual support on sleep in cancer</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Supportive Educational Intervention through virtual social networks on the sleep of cancer patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-08-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>66</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64033</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Formulas for determining the sample size are a minimum criterion, and the number of samples in each group can be increased depending on the project feasibility without imposing more cost on the study. Thus, in this study, we decided to add seven samples in each group to the specified minimum number of samples, which is not a problem in terms of methodology. Sampling was performed when patients were referred to the hospital for chemotherapy. Then the samples were randomly divided into two groups of 40 with random allocation in the intervention (A) and control (B) groups. First, the Quadruple blocks were defined as follows: ABAB, BBAA, BABA, BAAB, AABB, ABBA, etc., and were placed in an envelope and numbered, and the blocks were determined using a table of random numbers, and the individuals in terms of A and B They were divided into intervention and control groups. Patient A was in the supportive educational intervention group through Soroush virtual social network and patient B was in the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Insomnia. Condition 2: Sleepiness. Condition 3: Sleep quality.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants in the intervention group were contacted through a virtual social network allowing users to send and receive texts, photos, videos, and audio. The intervention group received supportive training messages on sleep in addition to routine care. The content of the messages was developed as a protocol based on the latest investigations and textbooks on cancer nursing and supportive care and was approved by the oncology department. The messages, including explanations about insomnia management, sleep quality, and strategies to improve sleep quality (sleep health, nutritional advice, place and time of sleep, relaxation techniques, and stress and anxiety management), were sent to the intervention group in two to three text messages with related pictures and audio and video files (8 am to 8 pm) every day for one month. The participants were asked to send the message "the message was read" to the researcher. If the message were not read for more than 24 hours, a reminder message would be sent. To ensure that educational content was understood, the participants were asked two to three questions at the end of each week to obtain feedback. The participants' questions were also answered. After finishing the intervention, the participants were asked to review the sent messages and report their sleep quality for one month. To support the participants, they were constantly monitored and encouraged to perform training. Intervention 2: Control group: The control group received routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can potentially be shared after unidentifiable individuals and also information about the main implications.

When:
Access period starts 6 months after the results are published

To whom:
The data will be available to researchers working in academic and scientific institutions.

Conditions:
Researchers working in academic institutions can submit requests for unidentified personal data or other documents.

Where to obtain:
To receive the data, send an email to the responsible author, Dr. Nazi Nejat.
N.nejat@arakmu.ac.ir

How to obtain:
After receiving the email, the data will be sent within one working week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elahe Sarlak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing., Third Floor., Blue Wing., Arak University of Medical Sciences., Payambar Azam University Complex., Basij sq., Arak Town</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6861967991</zip>
        <telephone>+98 66 4333 5104</telephone>
        <email>nazinejat@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Elahe Sarlak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing., Third Floor., Blue Wing., Arak University of Medical Sciences., Payambar Azam University Complex., Basij sq., Arak Town</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6861967991</zip>
        <telephone>+98 66 4333 5104</telephone>
        <email>sarlakelahe41@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The age range between 25-65 years
Definitive diagnosis of GIC (esophagus, stomach, liver, pancreas, and colorectal)
Chemotherapy treatment
Cancer awareness
Smartphone availability
Reading and writing ability
Absence of mental illnesses and underlying diseases causing sleep
No drug addiction
Getting a higher than average score in the Pittsburgh Sleep Quality Questionnaire and one of the two questionnaires of Insomnia Severity Index and Epworth Sleepiness Scale</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unwillingness to participate in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G47.0</hc_code>
      <hc_code>G47.2</hc_code>
      <hc_code>G47.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Disorders of initiating and maintaining sleep [insomnias]</hc_keyword>
      <hc_keyword>Delayed sleep phase syndrome .Irregular sleep-wake pattern</hc_keyword>
      <hc_keyword>Delayed sleep phase syndrome. Irregular sleep-wake pattern</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants in the intervention group were contacted through a virtual social network allowing users to send and receive texts, photos, videos, and audio. The intervention group received supportive training messages on sleep in addition to routine care. The content of the messages was developed as a protocol based on the latest investigations and textbooks on cancer nursing and supportive care and was approved by the oncology department. The messages, including explanations about insomnia management, sleep quality, and strategies to improve sleep quality (sleep health, nutritional advice, place and time of sleep, relaxation techniques, and stress and anxiety management), were sent to the intervention group in two to three text messages with related pictures and audio and video files (8 am to 8 pm) every day for one month. The participants were asked to send the message "the message was read" to the researcher. If the message were not read for more than 24 hours, a reminder message would be sent. To ensure that educational content was understood, the participants were asked two to three questions at the end of each week to obtain feedback. The participants' questions were also answered. After finishing the intervention, the participants were asked to review the sent messages and report their sleep quality for one month. To support the participants, they were constantly monitored and encouraged to perform training.</i_keyword>
      <i_keyword>Control group: The control group received routine care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sleep quality score in the Pittsburgh Sleep Quality Questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately and one month after the supportive educational intervention. Method of measurement: Pittsburgh Sleep Quality Index questionnaire.</prim_outcome>
      <prim_outcome>Insomnia severity score in Insomnia severity questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately and one month after the supportive educational intervention. Method of measurement: Insomnia Severity Index Questionnaire.</prim_outcome>
      <prim_outcome>Sleepiness score in the sleepiness Questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately and one month after the supportive educational intervention. Method of measurement: Eoworth sleepiness Scale Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-07-28</approval_date>
        <contact_name>Ethics committee of Arak University of Medical Sciences</contact_name>
        <contact_address>Basij Sq, Payambar Azam University Complex, Arak University of Medical Sciences, Blue Wing, Third Floor, School of Nursing, Arak, Iran Country: Iran Arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
